Helus Pharma (formerly Cybin Inc.) (HELP) — The company formerly known as Cybin commenced trading on the Nasdaq Global Market under the ticker HELP, doing business as Helus Pharma after its shares stopped trading on NYSE American on January 2.
The uplisting completes the transition announced in December and positions the clinical-stage developer of CYB003 (depression) and CYB004 (anxiety) alongside a larger biopharma peer group as it approaches multiple 2026 data readouts.
Source: businesswire.com
For the rest of that week's sector news, read our week in review.